Timber Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TMBR and other ETFs, options, and stocks.

About TMBR

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus is on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and other sclerotic skin diseases. 

CEO
John Koconis
CEOJohn Koconis
Employees
3
Employees3
Headquarters
Basking Ridge, New Jersey
HeadquartersBasking Ridge, New Jersey
Founded
2019
Founded2019
Employees
3
Employees3

TMBR Key Statistics

Market cap
13.45M
Market cap13.45M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
5.82M
Average volume5.82M
High today
$0.0914
High today$0.0914
Low today
$0.0872
Low today$0.0872
Open price
$0.0914
Open price$0.0914
Volume
5.53M
Volume5.53M
52 Week high
$0.8663
52 Week high$0.8663
52 Week low
$0.0826
52 Week low$0.0826

TMBR Earnings

-$0.15
-$0.10
-$0.05
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, After Hours
ActualExpected Nov 14, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.